Project cooperation
Looking for Clinical trial of early diagnosis of kidney damage in patients
Argeron Nephrotest is an advanced in vitro diagnostic solution designed for the early detection of kidney damage.
- Research
- Execution
- Biotechnology
CEO
Argeron Medikal Araştırma Sanayi ve Ticaret A.Ş.
Antalya, Türkiye
• Industrial Engineering Expertise: With a strong foundation in industrial engineering,
Professional Engagements Argeron Medical Ltd: Serves as a Director and Person with Significant Control (PSC), indicating involvement in strategic decision-making and company governance.
Strategic & Business Development Abilities
Business Strategy: Capable of formulating and executing business strategies that align with market trends and organizational goals.
Market Analysis: Skilled in analyzing market dynamics to identify opportunities for expansion and innovation.
Networking: Proficient in building and maintaining professional relationships that foster collaboration and business development.
Bülent BIDI's combination of engineering expertise, leadership experience, and entrepreneurial spirit positions him as a dynamic professional capable of driving innovation and growth within his ventures.
Project cooperation
Looking for Clinical trial of early diagnosis of kidney damage in patients
Argeron Nephrotest is an advanced in vitro diagnostic solution designed for the early detection of kidney damage.
Expertise
Advanced Medical and Biotechnology Solutions Medical Research and Diagnostic Development
*Innovation in Medical Diagnostics and Therapeutics *Biotechnology and Healthcare Solutions
Partnership
Early detection of kidney injury
Is an advanced in vitro diagnostic solution designed for the early detection of kidney damage.
Partnership
Argeron Magnetic Auto Injector
Is based on a unique permanent magnetic propulsion system, designed to deliver controlled and consistent injections